US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Wuhan General Group (China), Inc.

0.0001

0.0000

Volume:- -

Turnover:- -

Market Cap:3.39K

PE:0.00

High:0.0001

Open:0.0001

Low:0.0001

Close:0.0001

52wk High:0.0002

52wk Low:0.0000

Shares:33.93M

Float Shares:11.80M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3482

EPS(LYR):-0.3482

ROE:-8.78%

ROA:-0.50%

PB:0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Wuhan General Group (China), Inc.

Exchange:

EXPERT

Establishment Date:

- -

Employees:

700

Office Location:

6500 Transcanada hwy,Suite 400,Pointe-Claire,Quebec,Canada

Website:

http://www.wuhangeneral.com

Zip Code:

H9R 0A5

Phone:

Fax:

- -

Introduction:

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/WUHN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WUHN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WUHN\",,,,,undefined,":{"symbol":"WUHN","market":"US","secType":"STK","nameCN":"Wuhan General Group (China), Inc.","latestPrice":0.0001,"timestamp":1758052800000,"preClose":0.0001,"halted":0,"volume":0,"delay":15,"floatShares":11796600,"shares":33926500,"eps":-0.348218,"marketStatus":"Post-Mkt","change":0,"latestTime":"09-16 16:00:00 EDT Delay","open":0.0001,"high":0.0001,"low":0.0001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.348218,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1758067200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.0001,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WUHN\",,,,,undefined,":{"symbol":"WUHN","floatShares":11796600,"roa":"-0.50%","roe":"-8.78%","lyrEps":-0.348218,"shares":33926500,"dividePrice":0,"high":0.0001,"amplitude":0,"preClose":0.0001,"low":0.0001,"week52Low":0.000001,"pbRate":"0.00","psRate":"0.00","week52High":0.0002,"institutionHeld":0,"latestPrice":0.0001,"eps":-0.348218,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.348218,"open":0.0001,"prevYearClose":0.0001,"prevWeekClose":0.0001,"prevMonthClose":0.0001,"prevQuarterClose":0.0001,"fiveDayClose":0.0001,"twentyDayClose":0.0001,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WUHN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WUHN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WUHN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":32527206,"employeeNum":700,"address":"6500 Transcanada hwy,Suite 400,Pointe-Claire,Quebec,Canada","zipCode":"H9R 0A5","officePhone":"514-928-7368"},"stockCompanyDetail":{"websiteUrl":"http://www.wuhangeneral.com","stockEarnings":[{"period":"1week","weight":0.1956},{"period":"1month","weight":-0.2324},{"period":"3month","weight":-0.5672},{"period":"6month","weight":-0.4735},{"period":"1year","weight":-0.4055},{"period":"ytd","weight":-0.1956}],"description":"Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.","exchange":"EXPERT","name":"Wuhan General Group (China), Inc.","nameEN":"Wuhan General Group (China), Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"WUHN\",market:\"US\",,,undefined,":null}}